Ellipsis Health and Ceras Health Partner to Improve Early Detection of Mental Health Conditions Using Voice Biomarker Technology

Ellipsis Health and Ceras Health Partner to Improve Early Detection of Mental Health Conditions Using Voice Biomarker Technology

Ellipsis Health, the market leader in AI-generated voice biomarker technology, and Ceras Health, a leader in digital health solutions, today announced a partnership that will integrate Ellipsis Health's breakthrough technology that uses the human voice as a biomarker for mental health and wellbeing into Ceras' clinical monitoring platform. This integration will combine Ellipsis Health's AI and deep learning technology with Ceras Health's clinical monitoring and health data analytics platform, enabling real-time severity scores for anxiety and depression to improve care and triage patients in need. "This new partnership will advance the state of mental health care, enabling Ellipsis Health to put its cutting-edge voice technology to work - identifying people in need and then connecting them into integrated behavioral health services," said Mainul Mondal, founder and CEO, Ellipsis Health. Bringing technology-powered innovation to mental health care, Ellipsis Health is giving voice to a new standard of care, pioneering the only clinically validated vital sign for mental health. By harnessing the unique power of the human voice as a biomarker for mental wellbeing, along with machine learning and AI, Ellipsis Health identifies, measures, and monitors the severity of stress, anxiety, and depression at scale.




Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on May 29, 2024 at 11:21am